Antimicrobial peptide CC34 attenuates intestinal inflammation via downregulation of the NF-κB signaling pathway
- 4 August 2021
- journal article
- research article
- Published by Springer Nature in 3 Biotech
- Vol. 11 (9) , 1-13
Abstract
The investigational drug CC34 is a cation peptide with multiple bioactivities. Here, we studied the anti-inflammatory effects of CC34 in lipopolysaccharide (LPS)-treated mouse monocyte-macrophage cells (RAW264.7) and in mice with LPS-induced intestinal inflammation. In vitro, CC34 treatment with less than 50 μg/mL for 24 h did not induce cytotoxicity in RAW264.7 cells. Furthermore, CC34 significantly lowered the levels of select inflammatory cytokines, including TNF-α, IL-1β, and IL-6. Intracellular levels of reactive oxygen species (ROS) were lower in RAW264.7 cells treated with CC34 + LPS than in cells treated with LPS alone. Additionally, CC34 treatment suppressed iNOS and COX-2 mRNA levels in LPS-treated cells. We also observed that CC34 exerted anti-inflammatory activity by suppressing the phosphorylation of IKKβ, IκBα, and NF-κB p65 in vitro. Moreover, CC34 downregulated the release of inflammatory cytokines (TNF-α, IL-1β, and IL-6) in the jejunum tissue and serum of LPS-treated mice. We also found that the myeloperoxidase (MPO) levels were decreased, and the pathological damages were effectively abated in the jejunum tissue of CC34 + LPS-treated mice. In summary, we demonstrated that CC34 exerted anti-inflammatory activities, associated with the neutralization of LPS, inhibition of ROS, inhibition the NF-κB signaling pathway, and down-regulating the secretion of inflammatory cytokines. Thus, CC34 may represent an effective therapeutic strategy for intestinal inflammation.Keywords
Funding Information
- Innovative Research Group Project of the National Natural Science Foundation of China (32072759)
This publication has 44 references indexed in Scilit:
- Cytokines in inflammatory bowel diseaseNature Reviews Immunology, 2014
- Bidirectional regulation of NF-κB by reactive oxygen species: A role of unfolded protein responseFree Radical Biology and Medicine, 2013
- Kaempferol InhibitsP. intermediaLipopolysaccharide‐Induced Production of Nitric Oxide Through Translational Regulation in Murine Macrophages: Critical Role of Heme Oxygenase‐1‐Mediated ROS ReductionJournal of Periodontology, 2013
- Design of hybrid β-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activityBiomaterials, 2013
- Myeloperoxidase and oxidative stress in rheumatoid arthritisRheumatology, 2012
- Anti-inflammatory effects of ethanol extract from Orostachys japonicus on modulation of signal pathways in LPS-stimulated RAW 264.7 cellsBMB Reports, 2011
- Antimicrobial peptide P18 inhibits inflammatory responses by LPS- but not by IFN-γ-stimulated macrophagesBiotechnology Letters, 2008
- Role of cytokines in inflammatory bowel diseaseWorld Journal of Gastroenterology, 2008
- Current Limitations of IBD TreatmentAnnals of the New York Academy of Sciences, 2006
- The Interleukin-1β-Converting Enzyme Inhibitor Pralnacasan Reduces Dextran Sulfate Sodium-Induced Murine Colitis and T Helper 1 T-Cell ActivationThe Journal of Pharmacology and Experimental Therapeutics, 2004